We are determined to embrace innovation and pursue development through transformation. 2024 is a pivotal year for XCMG as we press ahead with our "Intelligent,Digital,and Connected Transformation" ...

Developing a strong passenger vehicle business has been a strategic focus for JAC Group since the tenure of Mr. Zuo Yan’an.

BEIJING, Sep 14 (China Economic Net) - The China International Fair for Trade in Services (CIFTIS) has emerged as a pivotal ...

A major event took place in Jiangbeizui on September 12, marking the signing, groundbreaking, and commissioning of key projects for the third quarter of 2024 in Jiangbei District and the completion of ...

中证网讯（记者 周璐璐）美国东部时间9月13日，生物制药公司Zenas BioPharma（简称：泽纳仕生物）正式在纳斯达克挂牌上市，股票代码：ZBIO。此次上市，泽纳仕生物发行价为17美元，计划发行1323.5万股，募资总额为2.25亿美元。上市首日，公司开盘价为18.35美元，较发行价上涨7.9%；收盘价为18.15美元，较发行价上涨6.76%；以收盘价计算，公司市值为6.95亿美元。

招股书显示，Zenas在2023年营收为5000万美元，2024年上半年无营收。Zenas在2024年上半年研发投入为5645万美元，上年同期的研发投入为3026万美元；管理费用1083万美元，上年同期的管理费用773万美元。

John Lee Ka-chiu, Chief Executive of China's Hong Kong Special Administrative Region, delivered a speech at the Summit, emphasizing that as China's most open and international city, Hong Kong is ...

西班牙首相桑切斯于9月8日至11日对中国进行正式访问。当前欧洲正面临乌俄冲突和巴以冲突升级的双重危机，欧盟内部关于对华政策的讨论也进入关键阶段。即将上任的新一届欧盟领导层应管控内部分歧，维护战略自主，同时重新审视对华政策，重视中国在推动世界和平方面的 ...